News

The IGCS Preinvasive Disease Program has just been upgraded.Modules from the 2nd phase of the online course (Advanced Theory) have undergone a major refresh — with streamlined lectures, new topics, and the most current global guidelines to keep you at the forefront of care. Now available in the IGCS Education360 Learning Portal, this program represents one of the most thorough educational programs in the world for teaching preinvasive disease knowledge and clinical skills.Enroll in the IGCS Preinvasive Disease ProgramNew & Updated TopicsPhase 2: Advanced Theory now includes 19 required and 5 optional lectures delivered by world-leading experts. Among the highlights:WHO and ASCO guideline updates for screening and treatmentHPV-related preinvasive disease and cancer in women living with HIVUpdated terminology in cytology, histopathology, and colposcopyNew diagnostic strategies, including self-sample HPV testingContemporary real-world vaccine outcomes and treatment approaches, from ablation to excisionNew lectures, including:• Follow-up after Treatment – Dr. Dawit Worku• Evidence on Single Dose Vaccine – Dr. Phil Castle• Anal Screening – Dr. Lisa FlowersNow Available on Education360 Learning PortalShorter, more focused lectures that highlight the most essential contentFresh updates across nearly every lecture, plus 4 brand-new lecturesBetter participant experience with easier navigation and seamless translations in 12 languagesNo retake required — past participants now have access to all updatesEnroll Today!The Program’s Global ImpactThis program (free for IGCS Members) provides a framework…

Uterine cancer is the second most common gynecological cancer globally, but often it is missing from national cancer plans and global health priorities. Without political attention, there is no accountability, no funding, and no progress. The position paper on uterine cancer “Spotlight on uterine cancer: Shaping access to equitable and high-quality care”, which IGCS co-authored with like-minded organizations from around the world, including AstraZeneca, is a call to governments and policymakers everywhere: the time to act is now. Launched at the 2025 Concordia Annual Summit, held alongside the United Nations General Assembly High-Level Meeting, the paper sets out clear, actionable steps to change the trajectory of uterine cancer. It calls for governments and health systems to integrate uterine cancer into national health strategies, invest in early detection so more women are diagnosed in time, and guarantee equitable access to care options and innovation. These are practical changes that can save lives, reduce disparities, and bring uterine cancer out of the shadows. We urge policymakers to listen, to act, and to put uterine cancer where it belongs – on the global health agenda. Position Paper – Spotlight on Uterine Cancer: Shaping Access to High Quality Care Released: September 22, 2025 View Paper This report reflects the contributions of IGCS Members, whose perspectives and expertise helped shape its recommendations. Abhishek Shankar —…

IGCS co-hosts a UNGA roundtable on women’s cancer care, advancing equity, access, and global policy impact through expert membership. Click to access the new global policy report on women’s cancer care from the Swedish Institute for Health Economics.